Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 304

Results For "IND"

6837 News Found

Health Ministry issues advisory to states in view of zika virus cases from Maharashtra
Policy | July 04, 2024

Health Ministry issues advisory to states in view of zika virus cases from Maharashtra

States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika


Dr. B.N. Gangadhar appointed as Chairperson of the National Medical Commission
People | July 04, 2024

Dr. B.N. Gangadhar appointed as Chairperson of the National Medical Commission

Dr. Sanjay Behari, Director of Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, as the President of the Medical Assessment and Rating Board


Aster Pharmacy to provide free random Blood Sugar and Blood Pressure check-ups at all its pharmacy outlets
Healthcare | July 03, 2024

Aster Pharmacy to provide free random Blood Sugar and Blood Pressure check-ups at all its pharmacy outlets

The initiative aims to empower individuals to take proactive steps towards monitoring their health


Aster Whitefield Hospital and government partner for free epilepsy camp in Kolar
Healthcare | July 03, 2024

Aster Whitefield Hospital and government partner for free epilepsy camp in Kolar

The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management


Avallano appoints Michael A. Ibara as Chief Strategy Officer
News | July 03, 2024

Avallano appoints Michael A. Ibara as Chief Strategy Officer

Ibara will drive AI-powered clinical research innovation


LG Chem enters Chinese osteoarthritis treatment market
News | July 03, 2024

LG Chem enters Chinese osteoarthritis treatment market

Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China


Lynparza and Imfinzi combination recommended for approval in the EU by CHMP for recurrent endometrial cancer
Drug Approval | July 02, 2024

Lynparza and Imfinzi combination recommended for approval in the EU by CHMP for recurrent endometrial cancer

Imfinzi also recommended for patients with mismatch repair deficient disease


Briefs: Family Care Hospitals, Laurus Labs and Bafna Pharmaceuticals
News | June 30, 2024

Briefs: Family Care Hospitals, Laurus Labs and Bafna Pharmaceuticals

Laurus Labs receives EIR from USFDA for API facilities


Alembic Pharmaceuticals announces USFDA final approval for Doxycycline Capsules, 40 mg
Drug Approval | June 29, 2024

Alembic Pharmaceuticals announces USFDA final approval for Doxycycline Capsules, 40 mg

Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients